X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Aventis Pharma with J.B.Chemicals - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SANOFI INDIA vs J.B.CHEMICALS - Comparison Results

SANOFI INDIA    Change

Sanofi India (the erstwhile Aventis Pharma), the 60% subsidiary of Sanofi-Aventis SA, France, is one of the largest pharma MNCs in India with a turnover of over Rs 13.2 bn in CY11. Domestic sales constituted 81% of total sales in CY11 and exports con... More

J.B.CHEMICALS 
   Change

JB Chemicals and Pharmaceuticals Limited (JBCPL), the flagship of the Unique Group, is one of the India's leading transnational pharmaceutical company. The company has 11 manufacturing facilities at four locations in India (Belapur, Ankleshwar, Panol... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SANOFI INDIA J.B.CHEMICALS SANOFI INDIA/
J.B.CHEMICALS
 
P/E (TTM) x 34.3 15.1 227.5% View Chart
P/BV x 6.5 2.4 274.1% View Chart
Dividend Yield % 1.4 0.2 849.3%  

Financials

 SANOFI INDIA   J.B.CHEMICALS
EQUITY SHARE DATA
    SANOFI INDIA
Dec-16
J.B.CHEMICALS
Mar-16
SANOFI INDIA/
J.B.CHEMICALS
5-Yr Chart
Click to enlarge
High Rs4,560318 1,433.5%   
Low Rs4,400200 2,205.5%   
Sales per share (Unadj.) Rs1,028.5148.0 695.0%  
Earnings per share (Unadj.) Rs129.019.1 675.8%  
Cash flow per share (Unadj.) Rs186.023.9 776.6%  
Dividends per share (Unadj.) Rs68.000.50 13,600.0%  
Dividend yield (eoy) %1.50.2 785.6%  
Book value per share (Unadj.) Rs753.6128.9 584.4%  
Shares outstanding (eoy) m23.0384.82 27.2%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.41.7 249.1%   
Avg P/E ratio x34.713.6 256.2%  
P/CF ratio (eoy) x24.110.8 222.9%  
Price / Book Value ratio x5.92.0 296.2%  
Dividend payout %52.72.6 2,012.6%   
Avg Mkt Cap Rs m103,17421,951 470.0%   
No. of employees `0003.62.7 132.5%   
Total wages/salary Rs m3,5921,841 195.1%   
Avg. sales/employee Rs Th6,537.74,590.9 142.4%   
Avg. wages/employee Rs Th991.4673.4 147.2%   
Avg. net profit/employee Rs Th819.8592.1 138.5%   
INCOME DATA
Net Sales Rs m23,68612,551 188.7%  
Other income Rs m708542 130.7%   
Total revenues Rs m24,39413,093 186.3%   
Gross profit Rs m5,2812,055 257.0%  
Depreciation Rs m1,313412 318.4%   
Interest Rs m1596 15.7%   
Profit before tax Rs m4,6612,088 223.2%   
Minority Interest Rs m00 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,691469 360.5%   
Profit after tax Rs m2,9701,619 183.5%  
Gross profit margin %22.316.4 136.2%  
Effective tax rate %36.322.5 161.5%   
Net profit margin %12.512.9 97.2%  
BALANCE SHEET DATA
Current assets Rs m15,6737,778 201.5%   
Current liabilities Rs m6,6784,358 153.2%   
Net working cap to sales %38.027.2 139.4%  
Current ratio x2.31.8 131.5%  
Inventory Days Days7655 139.0%  
Debtors Days Days2280 27.9%  
Net fixed assets Rs m8,0985,713 141.8%   
Share capital Rs m230170 135.8%   
"Free" reserves Rs m17,08810,547 162.0%   
Net worth Rs m17,35610,937 158.7%   
Long term debt Rs m00-   
Total assets Rs m25,40015,574 163.1%  
Interest coverage x311.722.8 1,366.0%   
Debt to equity ratio x00-  
Sales to assets ratio x0.90.8 115.7%   
Return on assets %11.811.0 106.8%  
Return on equity %17.114.8 115.6%  
Return on capital %26.920.0 135.0%  
Exports to sales %24.548.7 50.3%   
Imports to sales %28.07.1 395.2%   
Exports (fob) Rs m5,8016,115 94.9%   
Imports (cif) Rs m6,627889 745.7%   
Fx inflow Rs m7,1456,169 115.8%   
Fx outflow Rs m6,8461,285 532.7%   
Net fx Rs m2994,884 6.1%   
CASH FLOW
From Operations Rs m3,2261,397 231.0%  
From Investments Rs m-1,555-320 485.5%  
From Financial Activity Rs m-1,818-1,196 152.0%  
Net Cashflow Rs m-147-102 143.7%  

Share Holding

Indian Promoters % 0.0 55.4 -  
Foreign collaborators % 60.4 0.3 20,133.3%  
Indian inst/Mut Fund % 14.4 3.4 424.8%  
FIIs % 14.6 3.9 374.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 10.5 37.0 28.4%  
Shareholders   15,184 30,437 49.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SANOFI INDIA With:   NATCO PHARMA  PLETHICO PHARMA  WOCKHARDT LTD.  TORRENT PHARMA  FRESENIUS KABI ONCO.  

Compare SANOFI INDIA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Global Stock Markets Rebound After Sharp Weekly Drop(RoundUp)

Global financial markets rallied this week and brushed aside a rise in global borrowing costs while the dollar hit its lowest level since 2014.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

Here's What You Should Do in this Market Crash(The 5 Minute Wrapup)

Feb 6, 2018

The market correction has provided a golden opportunity to buy five high-quality safe stocks.

As the Market Corrects... It's Time to Buy More(Smart Contrarian)

Feb 5, 2018

The recent sell off in the stock market offers buying opportunity in some quality small caps.

The Era of Easy Money is Coming to an End. What Happens Now?(Vivek Kaul's Diary)

Feb 9, 2018

The easy money policy of the Federal Reserve of the United States, which drove up stock markets all over the world, is ending, with the Federal Reserve looking to shrink its balance sheet.

When Small is Not Always Beautiful(Chart Of The Day)

Feb 6, 2018

Big companies enjoying tax deductions and exemptions have an edge over the small companies.

What Should Mutual Fund Investors Do After LTCG Tax Norms(Outside View)

Feb 6, 2018

PersonalFN explain what investors should after LTCG tax norms.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

SANOFI INDIA SHARE PRICE


Feb 16, 2018 (Close)

TRACK SANOFI INDIA

  • Track your investment in SANOFI INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SANOFI INDIA 5-YR ANALYSIS

COMPARE SANOFI INDIA WITH

MARKET STATS